The Joint Pain Injections Market is divided into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies with regard to distribution channels

Pune, India -- (SBWire) -- 05/10/2019 --The Global Joint Pain Injections Market is estimated to grow at CAGR above 8 % over the forecast time frame 2019-2026 and reach the market value around USD 5.7 billion by 2026.

The global market is expected to expand between 2019 and 2026 to include an increase in the number of geriatric patients, an increase in awareness of joint disorders and high medical demands. Increasing the prevalence of joint pain amongst the population, demand for better treatment and development of healthcare infrastructure in various countries around the globe are expected to expand on the joint pain injection market.

Free Download Sample Report Pages for Better Understanding@
https://www.acumenresearchandconsulting.com/request-sample/1352

Increased Obesity Rate Resulting In Joint Pain

The risk of obesity for various joint disorders, particularly knee-related, including knee pain and knee osteoarthritis is considerable. World obesity has tripled since 1975, according to a fact sheet published by the WHO. 2016. 2016. Overweight was 1.9 billion, with over 650 million adults being obese. In addition, in 2016, around 41 million children under 5 years of age were obese. National Health and Nutrition Survey (NHANES) 2015-2016 indicates more than 1 in four kids aged between 2 and 19 years had obesity, and about 47 percent of adults had obesity. Increasing patient pool is estimated to increase healthcare spending in developing countries and developed countries on joint pain therapy and, in consequence, to promote the injections market for common pain.

Market Snapshots

Arthritis is the leading cause of disability in U.S. adults according to the facts published by Arthritis Foundation. About 54 million adults and 300,000 children and babies in the United States suffer from arthritis or rheumatic conditions. By 2040, more than 78 million people in the United States are likely to have arthritis diagnosed by doctors. In addition, the most common type of arthritis is osteoarthritis and affects some 31 million people in the United States. More and more arthritis increases the demand for disease-modifying treatments which are expected to propel joint pain injections during the forecast period.

The most common cause of joint pain and major disability and mobility among the population is arthritis. arthritis Current treatment options are not adequate as they are mainly aimed at relieving symptoms and mitigating pain. No drugs, such as osteoarthritis, are possible to cure, reverse or stop disease progression. Some patients are also incapable of finding relief by the treatments available and continue to suffer from pain. Hence, patients with joint pain have a large unmet need. This offers the chance for advance treatment options on the market for joint pain injections.

Hyaluronic acid injections are a highly attractive segment of the global pain injection market, followed by corticosteroid injections and other segments in terms of the injection type. This is due to the efficacy of hyaluronic acid injections in treating knee arthritis, which are contraindicated for other treatments. Viscosupplementation with hyaluronic acid in adults with knee osteoarthritis in the area of improved knee pain and function with minimal adverse effects accordingly is superior to intra-articular placebo and other traditional medicine, such as non-steroidal anti-inflammatory medicine(NSAID) published by CADTH.

View Detail Information with Complete TOC@
https://www.acumenresearchandconsulting.com/joint-pain-injections-market

Regional Stance

Due to a large pool of patients, increased geriatric populations, increased obesity and high acceptance of the region's advanced treatments for pain alleviation, North America dominated the worldwide joint injection market. During the forecast period, the region is estimated to remain dominant. U.S. FDA approved for the treatment of the knee arthritis viscosis supplementation with hyaluronic acid products. In the next few years, increasing healthcare expenses and investment are also key to boosting the joint pain injection market. The Asia-Pacific joint pain injection market is expected to expand with a major CAGR as join disorders are increased in developing countries and research initiatives are ongoing, and hyaluronic acid products will be manufactured in Japan.

Key Players & Strategies

Allergan Plc., Pfizer Inc., Sanofi, Ferring, B, Flexion Therapeutics, Inc.., Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. are major actors operating on the common pain injections market. Inc. Key players expand their product portfolio by combining, acquiring and cooperating with leading medical firms that are expected to improve the availability of the products and thus boost the market.

Browse All official Market Research Reports Press Releases@
https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Joint Pain Injections
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Joint Pain Injections Market By Type
1.2.2.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Joint Pain Injections Market Revenue Share By Type in 2017
1.2.2.3. Hyaluronic Acid Injections
1.2.2.4. Corticosteroid Injections
1.2.3. Joint Pain Injections Market By Joint Type
1.2.3.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Joint Type (2015-2026)
1.2.3.2. Global Joint Pain Injections Market Revenue Share By Joint Type in 2017
1.2.3.3. Knee and Ankle
1.2.3.4. Shoulder and Elbow
1.2.3.5. Hip Joint
1.2.3.6. Facet Joints of the Spine
1.2.4. Joint Pain Injections Market By Distribution Channel
1.2.4.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.4.2. Global Joint Pain Injections Market Revenue Share By Distribution Channel in 2017
1.2.4.3. Hospital Pharmacies
1.2.4.4. Online Pharmacies
1.2.4.5. Retail Pharmacies
1.2.5. Joint Pain Injections Market by Geography
1.2.5.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Joint Pain Injections Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Joint Pain Injections Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Joint Pain Injections Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Joint Pain Injections Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Joint Pain Injections Major Manufacturers in 2017

CHAPTER 4. JOINT PAIN INJECTIONS MARKET BY TYPE

4.1. Global Joint Pain Injections Revenue By Type
4.2. Hyaluronic Acid Injections
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Corticosteroid Injections
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. JOINT PAIN INJECTIONS MARKET BY JOINT TYPE

5.1. Global Joint Pain Injections Revenue By Joint Type
5.2. Knee and Ankle
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Shoulder and Elbow
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Hip Joint
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Facet Joints of the Spine
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. JOINT PAIN INJECTIONS MARKET BY DISTRIBUTION CHANNEL

6.1. Global Joint Pain Injections Revenue By Distribution Channel
6.2. Hospital Pharmacies
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Online Pharmacies
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Retail Pharmacies
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

7.1. North America Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Joint Pain Injections Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE JOINT PAIN INJECTIONS MARKET BY COUNTRY

8.1. Europe Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET BY COUNTRY

9.1. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

10.1. Latin America Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST JOINT PAIN INJECTIONS MARKET BY COUNTRY

11.1. Middle East Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA JOINT PAIN INJECTIONS MARKET BY COUNTRY

12.1. Africa Joint Pain Injections Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Allergan Plc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Pfizer Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Sanofi
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Ferring B.V.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Flexion Therapeutics, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Anika Therapeutics, Inc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. SEIKAGAKU CORPORATION
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Chugai Pharmaceutical Co., Ltd.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING@
https://www.acumenresearchandconsulting.com/inquiry-before-buying/1352

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report -
https://www.acumenresearchandconsulting.com/buy-now/0/1352

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.